Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 158

Sort by

Sort Order Select

Journal Articles

Efficacy of motixafortide plus G-CSF versus plerixafor plus G-CSF for stem cell mobilization and collection in multiple myeloma: A single-center comparative analysis and interim Results from a prospective study in poor mobilizers

Sara Close, Jun Liu, Lara Abousamra, Suhayla Sarhan, Kristine Geary, Sanjana Arji, Claire Shao, Eileen Green, Yuxin Liu, Paul Richardson, John Manis, Corey Cutler, Sarah Nikiforow, Clifton Mo

Blood (2025) 146 (Supplement 1): 4185.

https://doi.org/10.1182/blood-2025-4185

Published: 2025

Journal Articles

A multicenter phase 1 trial evaluating the safety and preliminary efficacy of revumenib as post-transplant maintenance after allogeneic hematopoietic cell transplant in patients with KMT2A-rearranged or NPM1-mutated acute leukemia

Brian Ball, Mahasweta Gooptu, Ling Li, Christopher Hourigan, Sally Mokhtari, Dongyun Yang, Leonardo Farol, Yazeed Samara, Anthony Selwyn Stein, Guido Marcucci, Monzr M. Al Malki, Corey Cutler, Ryotaro Nakamura, Ibrahim Aldoss

Blood (2025) 146 (Supplement 1): 5207.

https://doi.org/10.1182/blood-2025-5207

Published: 2025

Journal Articles

Cost-effectiveness of post-transplant gilteritinib maintenance in MRD-positive FLT3-ITD Acute Myeloid Leukemia: A microsimulation model based on the morpho trial

Tina Huang, Gregory Abel, Corey Cutler, Robert Soiffer, Richard Stone, Amar Kelkar

Blood (2025) 146 (Supplement 1): 4436.

https://doi.org/10.1182/blood-2025-4436

Published: 2025

Journal Articles

Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.

John Koreth, Maria Carmen Martinez Munoz, Jeremy Pantin, Shukaib Arslan, Jaime Sanz, Alison Loren, Benedetta Rambaldi, Elisa Sala, Avichai Shimoni, Tsila Zuckerman, Corey Cutler, Lisette Acevedo, Kham Phenis, Eugene Sun, Stephen Connelly, Joel Rothman

Blood (2025) 146 (Supplement 1): 274.

https://doi.org/10.1182/blood-2025-274

Published: 2025

Journal Articles

Early TCR diversity and recipient stem-cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Blood (2025) 146 (Supplement 1): 6065.

https://doi.org/10.1182/blood-2025-6065

Published: 2025

Journal Articles

Effect of graft cellular content on outcomes in HLA mismatched hematopoietic cell transplantation using post-transplant cyclophosphamide

Remy Dulery, Sandra Lee, Sarah Nikiforow, Carol Reynolds, Heather Garrity, Karl Stasko, Andrew Mason, Corey Cutler, John Koreth, Mahasweta Gooptu, Joseph Antin, Amar Kelkar, Vincent Ho, Catherine Wu, Rizwan Romee, Jerome Ritz, Robert Soiffer, Roman Shapiro

Blood (2025) 146 (Supplement 1): 4260.

https://doi.org/10.1182/blood-2025-4260

Published: 2025

Journal Articles

Ven+FluBu2 with ptcy/tac/MMF RIC transplant followed by venetoclax/azacitidine maintenance for high-risk MDS/AML

H. Moses Murdock, Kyle Hebert, Jennifer Brock, Elise Auriemma, Felicia Lim, Jeremy Ryan, Mahasweta Gooptu, Roman Shapiro, Corey Cutler, Amar Kelkar, Vincent Ho, Denbaa Bat-Erdene, Anthony Letai, Jerome Ritz, R. Coleman Lindsley, Joseph Antin, Robert Soiffer, Jacqueline Garcia

Blood (2025) 146 (Supplement 1): 4206.

https://doi.org/10.1182/blood-2025-4206

Published: 2025

Journal Articles

A novel, structured peer support intervention (STEPP) for patients undergoing hematopoietic stem cell transplantation: A pilot randomized clinical trial

Hermioni Amonoo, Emma Keane, Michelle Guo, Lisa Gudenkauf, Isabella Larizza, Emma Wolfe, Manfred Mate-Kole, Brian Healy, Corey Cutler, Heather Jim, Stephanie Lee, Joseph Greer, Jeffery Huffman, Areej El-Jawahri

Blood (2025) 146 (Supplement 1): 2489.

https://doi.org/10.1182/blood-2025-2489

Published: 2025

Journal Articles

Impact of graft versus host disease prophylaxis with post transplant cyclophosphamide on the prognostic value of HCT-CI

Ansh Mehta, Haesook Kim, Arcita Pramudita, Deborah Liney, Remy Dulery, Vincent Ho, Corey Cutler, John Koreth, Mahasweta Gooptu, Joseph Antin, Amar Kelkar, Sarah Nikiforow, Prashant Nageshwar, Catherine Wu, Jerome Ritz, Rizwan Romee, Robert Soiffer, Roman Shapiro

Blood (2025) 146 (Supplement 1): 4227.

https://doi.org/10.1182/blood-2025-4227

Published: 2025

Journal Articles

Acrobat interim results: Alloheme surveillance enables early detection of relapse in post-HCT AML and MDS patients

Monzr M. Al Malki, Corey Cutler, Ronald Sobecks, Iskra Pusic, Nelli Bejanyan, Sagar Patel, Arpita Gandhi, Vamsi Kota, Nabeel Rajeh, Piyanuch Kongtim, Chun-Po Fan, Yangyang Hao, Evgeniya Vaskova, Natali Gulbahce, Ashish Kothari, Nishant Dwivedi, Robert Woodward, Ran Reshef, Stefan Ciurea

Blood (2025) 146 (Supplement 1): 4301.

https://doi.org/10.1182/blood-2025-4301

Published: 2025

Journal Articles

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

Blood (2025) 145 (18): 1987–2001.

https://doi.org/10.1182/blood.2024025131

Published: 2025

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Axatilimab at 3 Different Doses in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

Blood (2023) 142 (Supplement 1): 1.

https://doi.org/10.1182/blood-2023-186963

Published: 2023

Journal Articles

A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet Count

Blood (2023) 142 (Supplement 1): 2246.

https://doi.org/10.1182/blood-2023-185315

Published: 2023

Journal Articles

Impact of Clinical and Genetic Factors on Myelofibrosis Outcomes after Allogeneic Transplantation

Mahasweta Gooptu, Haesook T. Kim, Kaina Chen, Ann Mullally, Joseph Antin, Corey Cutler, Amar H Kelkar, John Koreth, Roman M. Shapiro, Robert J. Soiffer, Daniel J. DeAngelo, Jacqueline S. Garcia, Marlise R. Luskin, Richard M Stone, Martha Wadleigh, Eric S. Winer, R. Coleman Lindsley, Vincent Ho

Blood (2023) 142 (Supplement 1): 4978.

https://doi.org/10.1182/blood-2023-178684

Published: 2023

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia - Retrospective Dual-Center Study

Blood (2023) 142 (Supplement 1): 4979.

https://doi.org/10.1182/blood-2023-179962

Published: 2023

Journal Articles

Feasibility of Utilizing a Virtual Health Assistant during Inpatient Reduced-Intensity Allogeneic Transplantation

Amar H Kelkar, Chantal Kerssens, Nicholas Groblewski, Dillon D Clancy, Hajime Uno, Corey Cutler, Danielle Sherman-Manhard, Robert J. Soiffer, Victor HS Wang, Gregory A Abel

Blood (2023) 142 (Supplement 1): 5104.

https://doi.org/10.1182/blood-2023-178619

Published: 2023

Journal Articles

Effective Prevention of Steroid-Requiring Chronic Graft-Vs.-Host Disease with B Cell Depletion: A Randomized, Placebo-Controlled Trial

Blood (2023) 142 (Supplement 1): 649.

https://doi.org/10.1182/blood-2023-180142

Published: 2023

Journal Articles

Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk

Blood (2023) 142 (Supplement 1): 3618.

https://doi.org/10.1182/blood-2023-185220

Published: 2023

Journal Articles

Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2176.

https://doi.org/10.1182/blood-2023-181863

Published: 2023

Journal Articles

Out-of-Pocket Costs and Financial Hardship Among Participants of the BMT CTN 1102 Study

Christopher T. Su, Wael Saber, Aasthaa Bansal, Li Li, Ryotaro Nakamura, Corey Cutler, Bart L. Scott, Lindsey R Sangaralingham, Viengneesee Thao, Joshua Roth, Winona Wright, Lotte Steuten, Deborah Mattila, Scott D Ramsey

Blood (2023) 142 (Supplement 1): 262.

https://doi.org/10.1182/blood-2023-187218

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Efficacy of motixafortide plus G-CSF versus plerixafor plus G-CSF for stem cell mobilization and collection in multiple myeloma: A single-center comparative analysis and interim Results from a prospective study in poor mobilizers

A multicenter phase 1 trial evaluating the safety and preliminary efficacy of revumenib as post-transplant maintenance after allogeneic hematopoietic cell transplant in patients with KMT2A-rearranged or NPM1-mutated acute leukemia

Cost-effectiveness of post-transplant gilteritinib maintenance in MRD-positive FLT3-ITD Acute Myeloid Leukemia: A microsimulation model based on the morpho trial

Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.

Early TCR diversity and recipient stem-cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Effect of graft cellular content on outcomes in HLA mismatched hematopoietic cell transplantation using post-transplant cyclophosphamide

Ven+FluBu2 with ptcy/tac/MMF RIC transplant followed by venetoclax/azacitidine maintenance for high-risk MDS/AML

A novel, structured peer support intervention (STEPP) for patients undergoing hematopoietic stem cell transplantation: A pilot randomized clinical trial

Impact of graft versus host disease prophylaxis with post transplant cyclophosphamide on the prognostic value of HCT-CI

Acrobat interim results: Alloheme surveillance enables early detection of relapse in post-HCT AML and MDS patients

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

Safety and Efficacy of Axatilimab at 3 Different Doses in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet Count

Impact of Clinical and Genetic Factors on Myelofibrosis Outcomes after Allogeneic Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia - Retrospective Dual-Center Study

Feasibility of Utilizing a Virtual Health Assistant during Inpatient Reduced-Intensity Allogeneic Transplantation

Effective Prevention of Steroid-Requiring Chronic Graft-Vs.-Host Disease with B Cell Depletion: A Randomized, Placebo-Controlled Trial

Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk

Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia

Out-of-Pocket Costs and Financial Hardship Among Participants of the BMT CTN 1102 Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only